What is the share price of Samrat Pharmachem Ltd (SAMRATPH) today?
The share price of SAMRATPH as on 28th September 2026 is ₹233.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Samrat Pharmachem Ltd (SAMRATPH) share?
The past returns of Samrat Pharmachem Ltd (SAMRATPH) share are- Past 1 week: 6.28%
- Past 1 month: -4.65%
- Past 3 months: 7.43%
- Past 6 months: 21.29%
- Past 1 year: -21.35%
- Past 3 years: -41.65%
- Past 5 years: 23.08%
What are the peers or stocks similar to Samrat Pharmachem Ltd (SAMRATPH)?
The peers or stocks similar to Samrat Pharmachem Ltd (SAMRATPH) include:What is the market cap of Samrat Pharmachem Ltd (SAMRATPH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Samrat Pharmachem Ltd (SAMRATPH) is ₹71.68 Cr as of 28th September 2026.What is the 52 week high and low of Samrat Pharmachem Ltd (SAMRATPH) share?
The 52-week high of Samrat Pharmachem Ltd (SAMRATPH) is ₹320 and the 52-week low is ₹190.What is the PE and PB ratio of Samrat Pharmachem Ltd (SAMRATPH) stock?
The P/E (price-to-earnings) ratio of Samrat Pharmachem Ltd (SAMRATPH) is -21.59. The P/B (price-to-book) ratio is 1.05.Which sector does Samrat Pharmachem Ltd (SAMRATPH) belong to?
Samrat Pharmachem Ltd (SAMRATPH) belongs to the Materials sector & Commodity Chemicals sub-sector.How to buy Samrat Pharmachem Ltd (SAMRATPH) shares?
You can directly buy Samrat Pharmachem Ltd (SAMRATPH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Samrat Pharmachem Ltd
SAMRATPH Share Price
BSE₹233.600.69% (+1.60)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SAMRATPH Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SAMRATPH Performance & Key Metrics
SAMRATPH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -32.43 | 1.05 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 24.37 | 3.07 | 1.43% |
SAMRATPH Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SAMRATPH Company Profile
Samrat Pharmachem Limited is engaged in the production of pharmaceutical chemicals like Iodine salts and Bromine salts. The Company's finished products are used in various industries, including pharmaceuticals, chemicals, food, fertilizer and salt.
SOLARINDS
PE Ratio
106.51
106.51
1Y Return
40.90%
40.90%
Buy Reco %
76.47
76.47
LINDEINDIA
PE Ratio
95.43
95.43
1Y Return
0.34%
0.34%
Buy Reco %
0.00
0.00
PE Ratio
45.58
45.58
1Y Return
50.13%
50.13%
Buy Reco %
0.00
0.00
SUMICHEM
PE Ratio
41.03
41.03
1Y Return
18.33%
18.33%
Buy Reco %
88.89
88.89
DEEPAKNTR
PE Ratio
39.32
39.32
1Y Return
15.37%
15.37%
Buy Reco %
58.82
58.82
SAMRATPH Forecast
SAMRATPH Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
SAMRATPH
SAMRATPH
Income
Balance Sheet
Cash Flow
Quarterly Normal View
SAMRATPH Income Statement
SAMRATPH Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 82.98 | 81.41 | 70.66 | 63.67 | 71.10 | 76.34 | 78.92 | 63.83 | 71.47 | 80.75 | ||||||||||
Operating & Other expenses | 81.33 | 78.24 | 66.81 | 59.49 | 71.08 | 75.53 | 79.23 | 64.08 | 73.02 | 78.86 | ||||||||||
EBITDA | 1.65 | 3.17 | 3.85 | 4.18 | 0.02 | 0.81 | -0.31 | -0.25 | -1.55 | 1.89 | ||||||||||
| Depreciation/Amortization | 0.16 | 0.16 | 0.17 | 0.17 | 0.16 | 0.17 | 0.18 | 0.19 | 0.19 | 0.19 | ||||||||||
| PBIT | 1.49 | 3.01 | 3.68 | 4.01 | -0.14 | 0.64 | -0.49 | -0.44 | -1.74 | 1.70 | ||||||||||
| Interest & Other Items | 0.11 | 0.19 | 0.17 | 0.10 | 0.22 | 0.44 | 0.26 | 0.13 | 0.14 | 0.11 | ||||||||||
| PBT | 1.38 | 2.82 | 3.51 | 3.91 | -0.36 | 0.20 | -0.75 | -0.57 | -1.88 | 1.59 | ||||||||||
| Taxes & Other Items | 0.00 | 0.75 | 0.86 | 1.13 | 0.04 | 0.44 | -0.16 | -0.11 | 0.16 | 0.71 | ||||||||||
| Net Income | 1.38 | 2.07 | 2.65 | 2.78 | -0.40 | -0.24 | -0.59 | -0.46 | -2.04 | 0.88 | ||||||||||
| EPS | 4.52 | 6.68 | 8.61 | 9.01 | -1.29 | -0.74 | -1.90 | -1.49 | -6.59 | 2.84 |
SAMRATPH Company Updates
SAMRATPH Stock Peers
SAMRATPH Past Performance & Peer Comparison
SAMRATPH Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsCommodity Chemicals
Compare valuation on Screener
MaterialsCommodity Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Samrat Pharmachem Ltd | -21.59 | 1.05 | — |
| Solar Industries India Ltd | 106.51 | 27.28 | 0.06% |
| Linde India Ltd | 95.43 | 12.28 | 0.20% |
| Himadri Speciality Chemical Ltd | 45.58 | 7.19 | 0.12% |
SAMRATPH Stock Price Comparison
Compare SAMRATPH with any stock or ETFCompare SAMRATPH with any stock or ETF
SAMRATPH
SAMRATPH Holdings
SAMRATPH Shareholdings
SAMRATPH Promoter Holdings Trend
SAMRATPH Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
SAMRATPH Institutional Holdings Trend
SAMRATPH Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
SAMRATPH Shareholding Pattern
SAMRATPH Shareholding Pattern
SAMRATPH Shareholding History
SAMRATPH Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing SAMRATPH stock
smallcases containing SAMRATPH stock
Looks like this stock is not in any smallcase yet.
SAMRATPH Events
SAMRATPH Events
SAMRATPH Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SAMRATPH Dividend Trend
No dividend trend available
SAMRATPH Upcoming Dividends
SAMRATPH Upcoming Dividends
No upcoming dividends are available
SAMRATPH Past Dividends
SAMRATPH Past Dividends
Cash Dividend
Ex DateEx DateSep 18, 2025
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 18, 2025
Cash Dividend
Ex DateEx DateSep 19, 2024
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 19, 2024
Cash Dividend
Ex DateEx DateSep 18, 2023
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 18, 2023
Cash Dividend
Ex DateEx DateSep 22, 2022
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 22, 2022
SAMRATPH Stock News & Opinions
SAMRATPH Stock News & Opinions
Articles & Videos
Corporate
Corporate
Samrat Pharmachem Limited to review quarterly results at board meeting on November 14Samrat Pharmachem Limited will hold a board meeting on November 14, 2026, to consider and approve the un-audited financial results for the quarter ended September 30, 2026, under Indian Accounting Standards (Ind-AS), according to a regulatory filing with the BSE Limited. The company will announce the results after the board meeting and will make them available on its website, www.samratpharmachem.com.
2 days agoCapital Market - Live
Corporate
Corporate
Samrat Pharmachem closes trading window for insiders ahead of quarterly resultsSamrat Pharmachem Limited informed the BSE Limited that the trading window for its designated persons and their immediate relatives will be closed from Thursday, October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter ended September 30, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
2 days agoCapital Market - Live
Corporate
Corporate
Samrat Pharmachem Limited named M/s Divyesh J Shah & Associates as its new auditorsSamrat Pharmachem Limited announced the appointment of M/s Divyesh J Shah & Associates as its statutory auditors, effective September 23, 2026, following the expiry of the tenure of M/s Shah & Savla LLP, which served as auditors for ten years. The appointment was approved by shareholders at the company’s 34th Annual General Meeting and M/s Divyesh J Shah & Associates will hold office until the conclusion of the 39th Annual General Meeting in 2031.
4 days agoCapital Market - Live
Corporate
Corporate
Samrat Pharmachem to hold annual meeting September 23, with e-voting facilitated by MUFG IntimeSamrat Pharmachem Limited will hold its 34th Annual General Meeting on Wednesday, September 23, 2026, at 1:00 P.M. IST via video conference or other audio visual means, with the company’s register of members and share transfer books closed from Sunday, September 20, 2026, to Tuesday, September 22, 2026, and remote e-voting available from Sunday, September 20, 2026, at 9:00 A.M. IST to Tuesday, September 22, 2026, at 5:00 P.M. IST, facilitated by MUFG Intime India Private Limited.
1 month agoCapital Market - Live
Corporate
Corporate
Samrat Pharmachem to hold board meetingSamrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 August 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Samrat Pharmachem to convene AGMSamrat Pharmachem announced that the 34th Annual General Meeting(AGM) of the company will be held on 23 September 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Samrat Pharmachem reports standalone net loss of Rs 2.04 crore in the March 2026 quarterNet Loss of Samrat Pharmachem reported to Rs 2.04 crore in the quarter ended March 2026 as against net loss of Rs 0.40 crore during the previous quarter ended March 2025. Sales rose 0.80% to Rs 71.77 crore in the quarter ended March 2026 as against Rs 71.20 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 3.31 crore in the year ended March 2026 as against net profit of Rs 7.11 crore during the previous year ended March 2025. Sales rose 1.35% to Rs 289.72 crore in the year ended March 2026 as against Rs 285.86 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales71.7771.20 1 289.72285.86 1 OPM %-1.730.18 --0.743.58 - PBDT-1.69-0.20 -745 -2.2610.53 PL PBT-1.88-0.36 -422 -2.989.88 PL NP-2.04-0.40 -410 -3.317.11 PL Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Samrat Pharmachem announces board meeting dateSamrat Pharmachem will hold a meeting of the Board of Directors of the Company on 30 May 2026.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Earnings
Samrat Pharmachem reports standalone net loss of Rs 0.46 crore in the December 2025 quarterNet loss of Samrat Pharmachem reported to Rs 0.46 crore in the quarter ended December 2025 as against net profit of Rs 2.78 crore during the previous quarter ended December 2024. Sales declined 0.36% to Rs 63.43 crore in the quarter ended December 2025 as against Rs 63.66 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales63.4363.66 0 OPM %-1.026.57 - PBDT-0.384.08 PL PBT-0.573.91 PL NP-0.462.78 PL Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Samrat Pharmachem to discuss resultsSamrat Pharmachem will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 10.11%, vs industry avg of 13.93%
Over the last 5 years, market share decreased from 0.23% to 0.22%